Seven Mount Sinai Health System hospitals have received top quality achievement awards from the American Heart Association for ensuring that patients with stroke, heart failure, and severe heart attacks receive the most appropriate and safest treatment for the best possible outcomes.

“Congratulations to our teams for these significant achievements that demonstrate Mount Sinai’s dedication to quality of care. The experts across our Health System have executed innovative approaches to diagnosis and treatment of stroke, heart failure, and heart attack,” said Kenneth L. Davis, President and Chief Executive Officer of the Mount Sinai Health System. “I commend them for their dedication to setting standards for excellence and making the care and safety of our patients a top priority.”

The Mount Sinai Hospital, Mount Sinai Beth Israel, Mount Sinai Brooklyn, Mount Sinai Morningside, Mount Sinai Queens, and Mount Sinai South Nassau received the Get With The Guidelines®-Stroke Gold Plus Quality Achievement Awards. The award recognizes each hospital’s commitment to ensuring that stroke patients receive the most appropriate treatment according to nationally recognized research-based guidelines based on the latest scientific evidence. Additionally, Mount Sinai West was honored with Get With The Guidelines®-Stroke Silver Plus award, which highlights its goal of treating patients with compliance to high standard levels of care.

Each of these Mount Sinai Health System hospitals earned the award by meeting specific quality achievement measures for the diagnosis and treatment of stroke patients at a set level for a designated period. These measures include evaluation of the proper use of medications and other stroke treatments aligned with the most up-to-date evidence-based guidelines with the goal of speeding recovery and reducing death and disability for stroke patients. Before discharge, patients should also receive education on managing their health and get a follow-up visit scheduled, and have access to help transitioning their care from a hospital to home setting.

Additionally, The Mount Sinai Hospital, Mount Sinai Beth Israel, and Mount Sinai South Nassau received the association’s Target: Stroke Elite Honor Roll Award. Mount Sinai

Queens received the Target: Stroke Honor Roll Award. Mount Sinai West received the Target: Stroke and Type 2 Diabetes Honor Roll Award, and Mount Sinai Morningside also received the Target: Type 2 Diabetes Honor Roll Award. To qualify for this recognition, hospitals must meet quality measures developed to reduce the time between the patient’s arrival at the hospital and treatment with the clot-buster tissue plasminogen activator, or tPA, the only drug approved by the U.S. Food and Drug Administration to treat ischemic stroke.

According to the American Heart Association/American Stroke Association, stroke is the No. 5 cause of death and a leading cause of adult disability in the United States. On average, someone in the United States has a stroke every 40 seconds and nearly 795,000 people experience a new or recurrent stroke each year. The “Get With The Guidelines” quality improvement initiative can often lead to fewer readmissions and lower mortality rates.

For cardiac care, The Mount Sinai Hospital, Mount Sinai Beth Israel, and Mount Sinai South Nassau also received Get With The Guidelines®-Heart Failure Gold Plus Award and Target: Heart Failure Honor Roll Award for implementing specific quality improvement measures outlined by the American Heart Association. This program helps hospital teams follow the most up-to-date research-based guidelines with the goal of speeding recovery and reducing hospital readmissions for heart failure patients. The hospitals earned these awards by meeting specific quality achievement measures for the diagnosis and treatment of heart failure patients at a set level for a designated period. These measures include evaluation of the patient, proper use of medications, and aggressive risk-reduction therapies, such as ACE inhibitors/ARBs, beta-blockers, diuretics, anticoagulants, and other appropriate therapies. Before patients are discharged, they must also receive education on managing their heart failure and overall health, schedule a follow-up visit, and have a plan to transition their care from hospital to home.

An estimated 6.2 million Americans are living with heart failure and its prevalence continues to rise, with more than 8 million Americans projected to be diagnosed by 2030. The chronic condition accounts for approximately 900,000 hospitalizations annually, which is nearly two hospitalizations every minute. Numerous published studies demonstrate the Get With The Guidelines®-Heart Failure programs have achieved significant improvements in patient outcomes including reducing 30-day readmissions.

Additionally, Mount Sinai Morningside has been honored with the Lifeline® Gold Plus Receiving Quality Achievement Award and Mount Sinai Beth Israel and The Mount Sinai Hospital have been given the Lifeline® Gold Receiving Quality Achievement Award. These recognize the implementation of specific quality improvement measures outlined by the American Heart Association for the treatment of patients who experience severe heart attacks.

Every year, more than 250,000 people experience an ST elevation myocardial infarction (STEMI), the deadliest type of heart attack, caused by a blockage of blood flow to the heart that requires timely treatment. To prevent death, it’s critical to restore blood flow as quickly as possible, either by mechanically opening the blocked vessel or by providing clot-busting medication. The American Heart Association’s Mission: Lifeline program’s goal is to reduce system barriers to prompt treatment for heart attacks, beginning with the 9-1-1 call, to EMS transport and continuing through hospital treatment and discharge. The initiative provides tools, training, and other resources to support heart attack care following protocols from the most recent evidence-based treatment guidelines.
Tags: Heart – Cardiology & Cardiovascular Surgery, Icahn School of Medicine at Mount Sinai, Mount Sinai Health System, The Mount Sinai Hospital, Kenneth L Davis, MD

About the Mount Sinai Health System

The Mount Sinai Health System is New York City’s largest academic medical system, encompassing eight hospitals, a leading medical school, and a vast network of ambulatory practices throughout the greater New York region. Mount Sinai is a national and international source of unrivaled education, translational research and discovery, and collaborative clinical leadership ensuring that we deliver the highest quality care—from prevention to treatment of the most serious and complex human diseases. The Health System includes more than 7,200 physicians and features a robust and continually expanding network of multispecialty services, including more than 400 ambulatory practice locations throughout the five boroughs of New York City, Westchester, and Long Island. The Mount Sinai Hospital is ranked No. 14 on U.S. News & World Report’s “Honor Roll” of the Top 20 Best Hospitals in the country and the Icahn School of Medicine as one of the Top 20 Best Medical Schools in country. Mount Sinai Health System hospitals are consistently ranked regionally by specialty and our physicians in the top 1% of all physicians nationally by U.S. News & World Report.

Alliance Oncology, a division of Alliance HealthCare Services, a leading national provider of outsourced healthcare services, announced the opening of Singing River Cancer Center (SRCC). SRCC will be a part of Alliance Cancer Care, one of the largest radiation cancer networks in the southeast with over 50 years of combined experience offered at five different locations throughout Northern Alabama.

“We are extremely excited about the opening of the new Singing River Cancer Center,” said Douglas McCracken, President of Alliance Oncology. “SRCC brings together an extensive suite of oncology services, multidisciplinary experts, and advanced technology to give residents of the Shoals area and surrounding communities first-class cancer care in one convenient location.”

Located in Florence, Alabama, SRCC is a 45,000 square foot state-of-the-art cancer center that will offer innovative technology and collaborative care in a community setting and serve patients locally and throughout greater Northwest Alabama. SRCC occupants will include Alliance Cancer Care (ACC), Clearview Cancer Institute (CCI), Helen Keller Imaging, and Surgical Associates of the Shoals.

For patients choosing radiation therapy treatments, ACC offers several types of radiation therapy designed to treat all forms and stages of cancer. Their board-certified radiation oncologists, physicists, dosimetrists, therapists, navigators, nursing staff, and counselors provide a custom treatment plan and resources that address each patient’s unique needs. Treatments include external beam radiation therapy (EBRT), intensity-modulated radiation therapy (IMRT), 3-D conformal therapy, image-guided radiation therapy (IGRT), stereotactic body radiation therapy (SBRT), stereotactic radiosurgery (SRS), and brachytherapy. Treatments are outpatient and noninvasive, with minimal to no recovery time.

Clearview Cancer Institute focuses on the diagnosis, treatment, follow-up after treatment, and prevention of all types of cancers and blood diseases. Their board-certified medical oncologists and hematologists provide the latest in cancer treatment options including immunotherapy, chemotherapy, and hormone therapy. Clearview will also offer a complete spectrum of state-of-the-art radiologic modalities, such as a wide-bore MRI, CT, X-ray, Ultrasound, Nuclear Medicine, and PET-CT. CCI offers many educational and complementary services for their patients undergoing cancer treatment including stage I-IV clinical trials, genetic testing and counseling, social services, financial services, lung cancer screening programs, and survivorship programs.

Helen Keller Hospital will provide 3-D Mammography services. They are the only organization to offer an on-site breast nurse navigator who works with the physicians to assist patients with a variety of needs from pre-screening through diagnosis and beyond.

Surgeons at Surgical Associates of the Shoals deliver surgical care in an experienced, individualized way, while still providing the latest, greatest excellence in surgery care their patients need. As members of the American College of Surgeons and board-certified by the American Board of Surgery, their surgeons are well versed in all areas of general surgery, including breast, colon/rectal?, endoscopy, skin and soft tissue, endocrine, minimally invasive, robotics, foregut, and in select areas of vascular and hepatobiliary surgery.

SRCC is proud to offer residents in the Shoals area and surrounding communities high-quality, multidisciplinary cancer care. With multiple services under one roof, patients can save time and money by having their cancer treatment close to home. In addition to healthcare and physician offices, SRCC will feature a café, chapel, and ample free parking.

Singing River Cancer Center is located at 180 Cox Creek Parkway South, Florence, Alabama 35630, and opens this month. For more information, please visit www.SingingRiverCancerCenter.com.

About Alliance HealthCare Services

Alliance HealthCare Services is a leading national provider of outsourced healthcare solutions, with expertise in radiology, oncology, and interventional services. We partner with healthcare providers, systems, and hospitals to provide a full continuum of services, including mobile, interim, fixed-site, and comprehensive service line management as well as ASCs and joint venture partnerships. Alliance operates more than 600 diagnostic radiology, radiation therapy, and interventional systems, including more than 70 fixed-site radiology locations, more than 40 cancer care centers, and more than 20 pain management/interventional procedures clinics. Alliance provides quality clinical services for over 1,100 hospitals and other healthcare partners in 47 states, where approximately 2,750 Alliance Team Members are committed to providing exceptional patient care and exceeding customer expectations.

Kratom tincture, the potent and effective way of experiencing kratom. Kratom tincture contains high-quality kratom that gives you the desired effects. To get the most out of your kratom powder, you should try out kratom tincture.

You can make kratom tincture at home using kratom powder. To get kratom powder, visit https://www.authentickratom.com/. Before learning how to make kratom tincture, you should know what it is and what are its benefits. So, let’s learn everything about kratom tincture!

What is Kratom Tincture?

Kratom tincture is the liquid form of kratom. The process of turning powder into kratom tincture can destroy the alkaloid compounds.

Destroying the alkaloid compounds can reduce the effects of kratom. It can make it less potent. So, manufacturers use professional techniques to preserve kratom‘s quality while turning it into a tincture.

These processes not only preserve the existing qualities but also enhance them. Turning kratom powder into tincture concentrates the effects of the particular kratom strain. It makes it more effective than the raw form of kratom.

For this reason, the use of kratom tincture is increasing.

The manufacturers combine ethanol with kratom to turn it into a tincture. The effects of ethanol and kratom combined together increases the potency of both.

There are various forms of kratom tincture such as:

• Raw Kratom Tincture
• Kratom and Other Herbs Tincture

Raw Kratom Tincture

The manufacturers of raw kratom tincture use raw form of kratom. The raw form of kratom means kratom leaves and not powder. Chewing or ingesting kratom leaves give you potent and long-lasting effects. That’s exactly the effect you get from raw kratom tincture.

Kratom and Other Herbs Tincture

Manufacturers have recently started mixing other herbs with kratom to make a tincture. This way, you can customize the effects you want to get from the tincture. Common tinctures of this type include kratom and CBD tincture.

Kratom and CBD combined give you more pain-relieving, relaxing, and energizing effects.

How to Make Kratom Tincture?

Making kratom tincture at home is easy, cheap, and fun. If you buy kratom tincture from a store, it might cost you more. But if you make it yourself, it might be cheap. You can make kratom tincture in an hour or two. But you need to let it sit for a while so that the alkaloid mixes properly.

But before learning how to make kratom tincture, let’s see which things you will need to make it!

Things You Need

Following are the things that you will need to make kratom tincture at home:

• Kratom Leaves or Powder
• Tincture Bottle
• pH Strips
• Citric Acid
• Ethanol
• Resealable Glass Jar
• Strainer

Step by Step Guide

Now that you know which things you need, it’s time to start making kratom tincture.

Prepare Everything

Before the mixing process of kratom tincture starts, you have to prepare everything. Take equal parts of kratom powder and100 proof ethanol. Put them both in a glass jar and mix them.

If you have kratom leaves, grind them and turn them into powder form before using. It is easier to mix the powder form of kratom with ethanol.

After mixing ethanol, add citric acid in the mixture. To check how much citric acid is enough, you need a pH strip.

Once the pH reaches four, stop adding citric acid. Mix it so that everything is well-combined.

Shake the Mixture

Shake the mixture at regular intervals for 3 hours. It will give you the best quality tincture. You don’t have to shake it for a lot of time, shaking it for a minute after every ten minutes is enough.

Store the Tincture

Storing the tincture in a suitable place is important. Store the tincture in a dark place. The temperature of the place should be less. The lower the temperature, the better it is for the tincture.

You have to let the tincture sit in the dark and cold place for 2 weeks. This will allow all the contents to mix thoroughly with each other.

Use the Tincture Bottle

After two weeks, take out the mixture from where you put it. Mix it again for an hour with regular intervals.

Before putting the tincture in the bottle, strain it. Discard the powder and use the liquid only. Put the liquid in the tincture bottle. There you go! Your tincture is ready!

Advantages of Using Tincture

You might be wondering, “Why should I use tincture instead of powder”? Well, there are a few advantages of using tincture over the powder form of kratom. Let’s learn about them!

High Potency

The tincture form of kratom is more potent than the powder form. A few drops of kratom tincture can give you the desired effects for up to 8 hours.

The liquid absorbs in your body quicker than powder. It means that kratom tincture affects you earlier than powders or extracts.

The ethanol mixed in kratom tincture increases the potency of kratom powder. So, you get intense effects from a small amount of kratom tincture.

Convenient and Portable

Using the kratom tincture is convenient. Working with powders can be messy. They can fly away and spread everywhere. But that’s not the case with kratom tinctures.

You can take the kratom tincture bottle anywhere with you. You won’t have to worry about the powder spilling everywhere. Storing powder is also difficult. It is not the case with tinctures as their bottles are resealable.

Convenient Shelving

You can save kratom tincture conveniently. But it’s not the case with kratom powder. Kratom powder pouches can’t be resealed once you open them. You have to store the powder in a jar. But, kratom tincture bottles are re-sealable. So, storing them is easier.

Conclusion

Kratom tinctures are more potent than powders and extracts. So, are you willing to give it a try?

You can use any strain to make kratom tincture. It only depends upon your preference. You can also mix a few strains to customize the effects.

UCSF Health has been named a 2020 “LGBTQ Healthcare Equality Leader” by the Human Rights Campaign (HRC) Foundation, the educational arm of the nation’s largest lesbian, gay, bisexual, transgender and queer (LGBTQ) civil rights organization.

This marks the 13th consecutive year in which UCSF Health has been recognized as an Equality Leader in the annual Healthcare Equality Index (HEI), which recognizes health care facilities for their dedication to providing inclusive care for LGBTQ patients and commitment to LGBTQ inclusion. UCSF Medical Center was the first major hospital in the nation to participate in the Index when it was created in 2007 and is the only institution to have received Equality Leader status every year since then.
exterior of building

“We are honored to have been recognized once again by the HRC Foundation for our ongoing efforts to provide the highest quality health care for our LGBTQ patients, their families and our employees,” said Mark R. Laret, chief executive officer and president of UCSF Health.

“As we have seen so vividly this year, equity in both health and society is not something that we can address once and be finished,” Laret said. “It requires a constant commitment not only to eliminating inequalities, but also to proactively educating ourselves, so that all members of our community feel included, respected and supported.”

HEI participants are scored on more than 50 criteria for LGBTQ patient-centered care, including discrimination protections, LGBTQ-specific training, patient services and support, employee support and benefits, and a public commitment to LGBTQ equality. To receive Equality Leader status, facilities must document that they meet most of these criteria and that they publicize their commitment to non-discrimination to patients, employees and the general public.

UCSF’s LGBTQ-inclusive policies, practices and training long predate the HEI. UCSF created the first dedicated LGBTQ office in health care or health education, convened the first annual LGBTQIA Health Forum for health professional students, housed the first and only Lesbian Health Research Center, and helped secure gender-affirming health coverage for all University of California students and employees, the first such coverage at any major U.S. employer.

UCSF is also renowned for its ground-breaking, life-saving leadership during the HIV/AIDS epidemic in the 1980s and beyond, via services, research, and education now clustered in the AIDS Research Institute. The UCSF School of Nursing and the Center for AIDS Prevention Studies also have led development of a new UCSF Center for Sexual and Gender Minority Health. In addition, UCSF Health’s LGBTQ-centered medical services include Transgender Care, the Alliance Health Project, the Child & Adolescent Gender Center Clinic, and the 360 Wellness Center.

UCSF is not resting on its laurels, however, according to Shane Snowdon, who founded UCSF’s LGBT Resource Center and returned to UCSF as a consultant in 2019 to review and optimize LGBTQ policies and practices.

“UCSF Health has undertaken a state-of-the-art, comprehensive assessment of its LGBTQ policies and practices, with the intention of offering the country’s very best care to LGBTQ patients and their families,” Snowdon said. “This wide-ranging assessment will help UCSF Health break new ground nationally in LGBTQ health equity, knowledge, and support.”

This year, 495 facilities earned the “LGBTQ Healthcare Equality Leader” designation, receiving a maximum score in each section and earning an overall score of 100. An additional 193 facilities earned a “Top Performer” designation, receiving between 80 to 95 points. The foundation noted that 90 percent of the participating facilities scored 80 points or more, indicating that these hospitals are going “beyond the basics” when it comes to adopting policies and practices in LGBTQ care. The foundation also proactively researched key policies at more than 1,000 non-participating hospitals nationwide, where the adoption of best practices is notably lower.

“From the previously unimaginable impact of the COVID-19 pandemic to the horrific incidents of racial violence targeting the Black community, the events of the past year have brought about so much pain and uncertainty,” said HRC President Alphonso David. “The health care facilities participating in the HRC Foundation’s Healthcare Equality Index (HEI) are not only on the front lines of the COVID-19 pandemic, they are also making it clear from their participation in the HEI that they stand on the side of fairness and are committed to providing inclusive care to their LGBTQ patients. In addition, many have made strong statements on racial justice and equity and are engaging in efforts to address racial inequities in their institutions and their communities. We commend all of the HEI participants for their commitment to providing inclusive care for all.”

UCSF Health is recognized worldwide for its innovative patient care, reflecting the latest medical knowledge, advanced technologies and pioneering research. It includes the flagship UCSF Medical Center, which is ranked among the top 10 hospitals nationwide, as well as UCSF Benioff Children’s Hospitals, with campuses in San Francisco and Oakland, Langley Porter Psychiatric Hospital and Clinics, UCSF Benioff Children’s Physicians and the UCSF Faculty Practice. These hospitals serve as the academic medical center of the University of California, San Francisco, which is world-renowned for its graduate-level health sciences education and biomedical research. UCSF Health has affiliations with hospitals and health organizations throughout the Bay Area.

Lung cancer is the deadliest cancer in America, and each year it claims more residents of Brooklyn than in other boroughs in New York City. To improve access to life-saving treatment, NYU Langone Hospital–Brooklyn and Perlmutter Cancer Center have launched a state-of-the-art lung cancer surgery program.

Travis Geraci, MD, a specialist in minimally invasive robotic lung and esophageal cancer surgery, has been appointed to spearhead an expansion of cardiothoracic surgical services in Brooklyn. He will be collaborating with an interdisciplinary team of pulmonologists, oncologists, and radiologists at NYU Langone Hospital–Brooklyn and Perlmutter Cancer Center–Sunset Park.

“Cancer care is inherently patient-focused and I am passionate about guiding each of my patients through the stages of care,” says Geraci. “I’m fortunate now to be able to build a top-notch surgical practice in a community that has long needed greater access to world-class cancer care.”

Geraci was fellowship-trained in robotic cardiothoracic surgery at NYU Langone under the mentorship of world-renowned robotic thoracic surgeons Robert Cerfolio, MD, MBA, and Michael Zervos, MD. Geraci specializes in the latest surgical techniques while using electromagnetic navigational bronchoscopy to locate tumors not found using conventional bronchoscopy.

As part of Perlmutter Cancer Center, a National Cancer Institute-designated Comprehensive Cancer Center, the Lung Cancer Center focuses on innovative, effective treatments for all types of cancers affecting the lungs, including non-small cell lung cancer, small cell lung cancer, and mesothelioma. Geraci will see patients at Perlmutter Cancer Center–Sunset Park.

“In just one year, we have built one of the most comprehensive cancer care facilities in Brooklyn,” says Abraham Chachoua, MD, associate director for cancer services at Perlmutter Cancer Center, noting the Sunset Park center’s one-year anniversary this summer. “Now we are continuing our expansion to address another pressing need in the community.”

The expansion of lung cancer surgery into Brooklyn will complement the diagnostic ability of NYU Langone Hospital–Brooklyn’s pulmonary medicine team, which uses the most advanced tools available, including radial endobronchial ultrasound, to locate suspicious growths deep within the airways of the lungs.

“We have made big strides in the level of care we are now able to deliver,” says Bret J. Rudy, MD, senior vice president and chief of hospital operations at NYU Langone Hospital–Brooklyn. “Our ever-expanding capabilities to address critical patient needs, such as second-to-none cancer care, is a testament to our commitment to this community and our neighbors.”

Cardiologs, a global leader in artificial intelligence (AI) cardiology diagnostics, announced an exclusive distribution agreement in France with MicroPort CRM, for the reselling of its cloud analysis solution for Holter ECGs. MicroPort CRM is a worldwide leader in the conception and distribution of implementable devices for the treatment of heart rhythm disorders and the leader in France of Holter ECG monitoring devices and software. This agreement marks the official launch, at a large scale, of Cardiologs’ European business operations.

As a pioneer in AI-based healthcare, Cardiologs is the first company to obtain a CE mark for an AI-based medical device. Cardiologs’ medical-grade AI automatically identifies cardiac rhythm disorders with a high level of accuracy and in a timely manner, cutting diagnosis and analysis time in half. Thanks to its secure cloud solution, which General Data Protection Regulations (GDPR) compliant and “Hébergeur de Données de Santé” (HDS) certified, the analysis is available in real-time, from everywhere, by all professionals involved in a patient’s care, thus simplifying the logistics of ECG diagnostics.

Cardiologs is device-agnostic and can interpret data from a broad range of cardiac monitoring devices, a choice aligned with the evolution of health tech towards greater openness and interoperability. Already in use in several healthcare facilities, Cardiologs’ solution has been immediately endorsed by the medical staff, as Dr. Laurent Fiorina, rythmolog at Institut Cardiovasculaire de Paris-Sud (France) and medical expert at Cardiologs confirms, “Cardiologs’ solution enabled us to be more efficient and doubled our Holter analysis capacity. We are now capable of providing our patients with fast and accurate ECG analysis. The ease of use was a major reason for the team’s fast endorsement of this new ECG analysis device.”

Yann Fleureau, co-founder and CEO of Cardiologs, said, “We are extremely enthusiastic to partner with MicroPort CRM for the distribution of our unique technology in France. Its leading position in the Holter market combined with the expertise of its business teams, makes MicroPort CRM an ideal business partner to widely distribute Cardiologs’ solution to all the French cardiologists in hospitals as well as in outpatient medical offices.”

Benoît Clinchamps, President of MicroPort CRM, added, “We are very happy to launch this partnership with Cardiologs which perfectly reflects MicroPort CRM’s strategy: to offer new unique and innovative services that enable healthcare facilities and cardiologists to optimize their time, resources and improve patient diagnostics.”

France Schwarz, Director of Marketing Europe at Cardiologs added, “This agreement confirms our solution’s attractiveness and marks the first phase of our European marketing strategy.”

About Cardiologs
Cardiologs is a medical technology company committed to transforming cardiac diagnostics using medical-grade artificial intelligence and cloud technology. Developed in partnership with leading physicians, the Cardiologs ECG Analysis Solution empowers clinicians worldwide to deliver expert cardiac care faster and more efficiently. CE-Marked and FDA cleared for detection of 14 cardiac arrhythmias, the Cardiologs ECG Analysis Solution is built on a growing database of more than 5 million ECG recordings and is supported by a number of clinical publications.

For more information: https://cardiologs.com/

About MicroPort CRM
Pioneering physiological therapies in cardiac rhythm management. Driven by our expert R&D teams and state-of-the-art manufacturing facilities across the globe, MicroPort CRM conceives, designs and develops solutions for the management of cardiac rhythm disorders and heart failure. Headquartered in Paris, our precise technologies are manufactured in France, Italy, the Dominican Republic; and for the Chinese market, in China.